Navigation Links
Graphene plasmonics beats the drug cheats
Date:1/13/2013

Writing in Nature Materials, the scientists, working with colleagues from Aix-Marseille University, have created a device which potentially can see one molecule though a simple optical system and can analyse its components within minutes. This uses plasmonics the study of vibrations of electrons in different materials.

The breakthrough could allow for rapid and more accurate drug testing for professional athletes as it could detect the presence of even trace amounts of a substance.

It could also be used at airports or other high-security locations to prevent would-be terrorists from concealing explosives or traffickers from smuggling drugs. Another possible use could be detecting viruses people might be suffering from.

Graphene, isolated for the first time at The University of Manchester in 2004, has the potential to revolutionise diverse applications from smartphones and ultrafast broadband to drug delivery and computer chips.

It has the potential to replace existing materials, such as silicon, but University of Manchester researchers believe it could truly find its place with new devices and materials yet to be invented.

The researchers, lead by Dr Sasha Grigorenko, suggested a new type of sensing devices: artificial materials with topological darkness. The devices show extremely high response to an attachment of just one relatively small molecule. This high sensitivity relies on topological properties of light phase.

To test their devices, researches covered them with graphene. They then introduced hydrogen onto the graphene, which allowed them to calibrate their devices with far superior sensitivity than with any other material.

Testing for toxins or drugs could be done using a simple blood test, with highly-accurate results in minutes. The researchers found that the sensitivity of their devices is three orders of magnitude better than that of existing models.

The academics, from the School of Physics and Astronomy, hope the research will show the practical applications from an emerging area of research singular optics.

Dr Grigorenko said: "The whole idea of this device is to see single molecules, and really see them, under a simple optical system, say a microscope.

"The singular optics which utilise the unusual phase properties of light is a big and emerging field of research, and we have shown how it can have practical applications which could be of great benefit.

"Graphene was one of the best materials we could have used to measure the sensitivity of these molecules. It is so easy to put the hydrogen on to it in controlled way.

"We are only starting to scratch the surface of what this research might tell us but it could have profound implications for drug detection, security and viruses."


'/>"/>

Contact: Daniel Cochlin
daniel.cochlin@manchester.ac.uk
44-161-275-8387
University of Manchester
Source:Eurekalert

Related biology news :

1. High-resolution atomic imaging of specimens in liquid by TEM using graphene liquid cell
2. Using graphene, scientists develop a less toxic way to rust-proof steel
3. New analysis of premature infants heartbeats, breathing could be cues for leaving NICU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... and GREENWICH, Conn. , Feb. ... firm focused on venture growth investments in biotechnology ... Josh Richardson , M.D. to Managing Director. ... biotechnology companies.  He is a board observer at ... in Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, ...
(Date:2/16/2017)... CALABASAS, Calif. , Feb. 16, 2017 /PRNewswire/ ... on developing groundbreaking therapies to treat severe neurological ... in children treated with AGT-181, the company,s investigational ... syndrome (also known as mucopolysaccharidosis type I, or ... Phase 2 proof-of-concept (POC) study, presented today at ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... infusion of innovative telemedicine application, new and leading ... are experiencing a boom worldwide. The healthcare sector ... of technologies, services and new therapies for companies ... (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology: